ArticleCancer immunology, immunotherapy : CII2016

The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.

Mastewal Abuhay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.